Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy

Importance of chemoresistant tuberculosis (CRTB) is undoubted both in Ukraine and all over the world. Especially alarming fact is that together with high CRTB sickness rate among young working-age people there is the low efficiency of therapy (55 %). Data of many researchers show, that tuberculosis...

Full description

Bibliographic Details
Main Authors: O. M. Raznatovska, V. H. Siusiuka, A. V. Fedorec, A. I. Pyroh, H. I. Makurina
Format: Article
Language:English
Published: Zaporozhye State Medical University 2020-07-01
Series:Patologìâ
Subjects:
Online Access:http://pat.zsmu.edu.ua/article/view/203868/204708
id doaj-f6f8059cd6fb46b3bf39e53ac014fa2b
record_format Article
spelling doaj-f6f8059cd6fb46b3bf39e53ac014fa2b2020-11-25T03:04:12ZengZaporozhye State Medical UniversityPatologìâ2306-80272310-12372020-07-0117112713210.14739/2310-1237.2020.1.203868Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancyO. M. Raznatovska0https://orcid.org/0000-0003-2252-9063V. H. Siusiuka1 A. V. Fedorec2A. I. Pyroh3 H. I. Makurina4Zaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineMunicipal Institution “Zaporizhzhia Regional TB Clinical Dispensary”, Ukraine.Municipal Institution “Zaporizhzhia Regional TB Clinical Dispensary”, UkraineZaporizhzhia State Medical University, UkraineImportance of chemoresistant tuberculosis (CRTB) is undoubted both in Ukraine and all over the world. Especially alarming fact is that together with high CRTB sickness rate among young working-age people there is the low efficiency of therapy (55 %). Data of many researchers show, that tuberculosis of pregnant women is the reason of many significant complications which make serious maternal and perinatal danger. The problem of CRTB for pregnant woman is especially dangerous because the patient should take antimycobacterial drugs of II grade for a long period and these drugs have teratogenic effect. Purpose. Familiarization of physician-practitioners with the clinical features of the course and treatment of CRTB in women during pregnancy. Materials and methods. 4 clinical cases of own observations of the course and treatment of CRTB in women during pregnancy were described. Results. Among our investigations the artificial termination of pregnancy was inevitable in 3 of 4 presented clinical cases. The first patient had tubal pregnancy. The second patient: together with medical indications for artificial termination of pregnancy (multiresistant tuberculosis, unstable position of fetus), the absence of the patient’s tendency for treatment of multiresistant tuberculosis and problem social factor were observed. The patient informed that pregnancy was undesirable. The third patient had polyresistant tuberculosis and generalized destructive tuberculosis in lungs and besides the artificial termination of pregnancy was also her decision. The fourth patient had medical indications for artificial termination of pregnancy (multiresistant tuberculosis, negative clinical and radiological dynamics) but she refused. With regard to refusal antimicrobial therapy was corrected and aminoglycosides were excluded. The patient was responsible as to her own health and treatment of multiresistant tuberculosis. Under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist she terminated complete course of antimicrobial therapy with successful treatment result and gave birth to healthy baby. Conclusions. Summarizing our own observations of the pregnant patients with CRTB the following conclusion can be made: if patients with CRTB have tendency to antimicrobial therapy and desire to give birth the positive results such as CRTB treatment and delivery of healthy baby will be obtained under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist. http://pat.zsmu.edu.ua/article/view/203868/204708chemoresistanttuberculosispregnancy
collection DOAJ
language English
format Article
sources DOAJ
author O. M. Raznatovska
V. H. Siusiuka
A. V. Fedorec
A. I. Pyroh
H. I. Makurina
spellingShingle O. M. Raznatovska
V. H. Siusiuka
A. V. Fedorec
A. I. Pyroh
H. I. Makurina
Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
Patologìâ
chemoresistant
tuberculosis
pregnancy
author_facet O. M. Raznatovska
V. H. Siusiuka
A. V. Fedorec
A. I. Pyroh
H. I. Makurina
author_sort O. M. Raznatovska
title Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
title_short Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
title_full Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
title_fullStr Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
title_full_unstemmed Clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
title_sort clinical cases of management and treatment of women with chemoresistant tuberculosis during pregnancy
publisher Zaporozhye State Medical University
series Patologìâ
issn 2306-8027
2310-1237
publishDate 2020-07-01
description Importance of chemoresistant tuberculosis (CRTB) is undoubted both in Ukraine and all over the world. Especially alarming fact is that together with high CRTB sickness rate among young working-age people there is the low efficiency of therapy (55 %). Data of many researchers show, that tuberculosis of pregnant women is the reason of many significant complications which make serious maternal and perinatal danger. The problem of CRTB for pregnant woman is especially dangerous because the patient should take antimycobacterial drugs of II grade for a long period and these drugs have teratogenic effect. Purpose. Familiarization of physician-practitioners with the clinical features of the course and treatment of CRTB in women during pregnancy. Materials and methods. 4 clinical cases of own observations of the course and treatment of CRTB in women during pregnancy were described. Results. Among our investigations the artificial termination of pregnancy was inevitable in 3 of 4 presented clinical cases. The first patient had tubal pregnancy. The second patient: together with medical indications for artificial termination of pregnancy (multiresistant tuberculosis, unstable position of fetus), the absence of the patient’s tendency for treatment of multiresistant tuberculosis and problem social factor were observed. The patient informed that pregnancy was undesirable. The third patient had polyresistant tuberculosis and generalized destructive tuberculosis in lungs and besides the artificial termination of pregnancy was also her decision. The fourth patient had medical indications for artificial termination of pregnancy (multiresistant tuberculosis, negative clinical and radiological dynamics) but she refused. With regard to refusal antimicrobial therapy was corrected and aminoglycosides were excluded. The patient was responsible as to her own health and treatment of multiresistant tuberculosis. Under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist she terminated complete course of antimicrobial therapy with successful treatment result and gave birth to healthy baby. Conclusions. Summarizing our own observations of the pregnant patients with CRTB the following conclusion can be made: if patients with CRTB have tendency to antimicrobial therapy and desire to give birth the positive results such as CRTB treatment and delivery of healthy baby will be obtained under complex simultaneous control of phthisiatrician, obstetrician-gynecologist and neonatologist.
topic chemoresistant
tuberculosis
pregnancy
url http://pat.zsmu.edu.ua/article/view/203868/204708
work_keys_str_mv AT omraznatovska clinicalcasesofmanagementandtreatmentofwomenwithchemoresistanttuberculosisduringpregnancy
AT vhsiusiuka clinicalcasesofmanagementandtreatmentofwomenwithchemoresistanttuberculosisduringpregnancy
AT avfedorec clinicalcasesofmanagementandtreatmentofwomenwithchemoresistanttuberculosisduringpregnancy
AT aipyroh clinicalcasesofmanagementandtreatmentofwomenwithchemoresistanttuberculosisduringpregnancy
AT himakurina clinicalcasesofmanagementandtreatmentofwomenwithchemoresistanttuberculosisduringpregnancy
_version_ 1724682294337208320